等待開盤 12-12 09:30:00 美东时间
+0.500
+2.64%
Mark Cuban slammed major insurers for mistreating independent doctors and argued that the Affordable Care Act has been overtaken by corporate abuse, saying the law is now "garbage" and must be replaced as Washington battles over the future of ACA subsidies.
12-05 13:00
HealthEquity (NASDAQ:HQY) is gearing up to announce its quarterly earnings on W...
12-02 22:01
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从4美元升至9美元;BTIG:维持Cullinan Therapeutics"买入"评级,目标价从32美元升至38美元
11-25 10:27
https://www.politico.com/newsletters/inside-congress/2025/11/24/trumps-obamacare-move-blindsides-conservatives-00666700
11-24 19:16
Alignment Healthcare will present at the Piper Sandler 37th Annual Healthcare Conference on Dec. 3, 2025, at 10 a.m. EST in New York. A webcast and replay will be available on their investor relations website.
11-19 13:00
今日重点评级关注:HC Wainwright & Co.:维持Caribou Biosciences"买入"评级,目标价从3美元升至9美元;HC Wainwright & Co.:上调CervoMed评级至"买入",目标价从11美元升至25美元
11-06 09:55
Cigna expects 2026–2027 margin pressure from its new rebate-free PBM model as major clients renew at lower margins, prompting analyst target cuts.
11-05 02:55
今日重点评级关注:花旗:维持Caribou Biosciences"买入"评级,目标价从5美元升至8美元;HC Wainwright & Co.:上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入",目标价30美元
11-04 10:31
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
11-03 20:20
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Alignment业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **第三季度核心财务表现:** - **营收(Revenue)**:9.94亿美元,同比增长44% - **调整后毛利润(Adjusted Gross Profit)**:1.27亿美元,同比增长58% - **调整后EBITDA**:3200万美元,EBITDA利润率为3.3% - **现金及现金等价物**:季末持有6.44亿美元 - **健康计划会员数**:229,600名会员,同比增长26% **全年财务指导上调:** - **营收指导**:中位数上调4100万美
11-01 12:35